Genetic engineering of infectious rabies virus by Conzelmann, Karl-Klaus
3rd Quarter: July - September 1994 page 11 
4.4 Genetic Engineering of Infectious Rabies Virus 
by K. -K. Conzelmann 
Federal Research Centre for Virus Diseases of Animals, Paul-Ehrlich-Str. 28, D-72076 Tübingen 
The genetic manipulat-
ion of animal viruses has led to 
extraordinary advances in the 
understanding of how viruses 
replicate, how they interact 
with the host cell, and what 
determines virulence. In ad-
dition, genetically altered virus-
es have been successfully used 
to express foreign genes and to 
generate efficient recombinant 
vaccines. 
Viruses con ta in ing 
DNA, such as SV40- (1), Her-
pes-, Adeno-, and Poxviruses 
were the first to become am-
enable to genetic manipulation. 
After transfection into cells, the 
DNA of many of these viruses 
is infectious per se and gives 
rise to infectious particles. 
Al ternat ive ly , homologous 
recombination can be used to 
introduce defined DNA into 
the genomes of helper virus. 
For some time, viruses 
with a positive stranded RNA 
genome (Picornaviruses, A l -
phaviruses) have been amen-
able to specific alteration (2). 
The genomic RNA of positive 
strand RNA viruses serves as 
mRNA and is infectious after 
introduction into a cell. Either 
RNAs transcribed in vitro from 
recombinant cDNA and then 
transfected into a cell or 
RNAs generated intracellular^ 
from transfected cDNA may 
yield infectious virus. 
The genetic engineering 
of negative stranded RNA 
viruses proved to be much 
more complicated. This group 
of viruses include many impor-
tant human and animal patho-
gens, such as influenza, parain-
fluenza, respiratory syncytial, 
measles, and rabies viruses. 
Neither the naked genomic 
RNA nor the complementary 
(positive sense) RNA is infec-
tious after transfection into 
cells. However, we recently 
showed for the first time that 
recombinant RNA correspon-
ding to the entire genome of a 
negative stranded RNA virus, 
namely the rhabdovirus rabies 
virus, can be made infectious 
(3). This was achieved by 
simultaneous intracellular ex-
pression of the proteins consti-
tuting the viral polymerase 
complex and the viral RNA. 
A full-length genomic 
cDNA copy of the rabies virus 
strain SAD B19, which is 
being used as a live vaccine 
for oral immunization of foxes, 
was cloned between a T7 RNA 
polymerase promoter and a 
hepatitis delta virus ribozyme 
sequence. After transfection of 
the plasmid into cells infected 
previously with a recombinant 
vaccinia virus providing T7 
RNA polymerase, full-length 
12 kb RNA with precise ends 
was produced. In addition, 
three other T7 RNA poly-
merase driven plasmids were 
co- transfected. They expressed 
the rabies virus Ν, P, and L 
proteins, which make up the 
v i ra l polymerase complex. 
Assembly of the plasmid en­
coded RNA and the proteins 
into transcriptionally active 
rabies virus nucleocapsids and 
subsequently autonomous 
expression of the envelope 
proteins Μ and G resulted in 
the formation of infectious 
rabies virus. 
Site specific alterations 
were then introduced into the 
genomic cDNA copy in order 
to probe the genome flexibility 
of rabies virus and to generate 
viruses which are distinguish­
able from standard SAD B19 
virus. The first experiments 
concentrated on the variable 
pseudogene region between the 
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G and L gene, which is present 
in all natural rabies viruses 
and which is being used to 
discriminate closely related 
rabies virus isolates in molecul-
ar epidemiology studies. Re-
combinant infectious viruses 
possessing the introduced 
genetic tags, namely insertions 
or deletions of four nucleotides 
at various locations, were suc-
cessfully recovered. Even a 
virus lacking the entire pseudo-
gene sequence could be isolat-
ed. Growth characteristics and 
final titers were identical to 
those of the SAD B19 virus, 
demonstrating that the pseudo-
gen is not essential for pro-
pagation of rabies virus, at 
least in cell culture. In addition, 
recombinant viruses wi th 
alterations within coding reg-
ions resulting in amino acid 
exchanges in the viral G and L 
proteins could be recovered. 
Most likely, recombinant rabies 
viruses mutated in all parts of 
the genome can be generated in 
the future. Since the vaccinia 
viruses, which are initially 
needed in the transfection ex-
periments, can be removed 
easily from the culture super-
natants by f i l t ra t ion , pure 
stocks of recombinant rabies 
viruses are obtained. 
It is now possible to do 
structure/function studies of 
rabies virus genes and proteins 
and also to investigate virus-
host interactions in detail. By 
using specifically designed 
mutant viruses, the mechanisms 
involved in rabies neurotrop-
ism, latency and pathogenesis 
may be revealed. It is also now 
feasible to identify virulence 
markers and to design safe 
attenuated, genetically marked 
viruses for use as live vaccines. 
Moreover, it is likely 
that rabies virus possesses the 
capacity to express foreign 
genes. It was possible to intro-
duce into the pseudogene of a 
recombinant virus a functional 
transcription signal copy from 
another part of the genome 
resulting in generation of an 
additional transcription unit. As 
bacterial and eukaryotic repor-
ter genes have already been 
expressed from defective virus-
like-particles (4), it appears 
probable that infectious rabies 
virus might find useful applic-
ation as a vector for the expres-
sion of foreign genes. 
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